Pregnancy-associated plasma protein-A (PAPP-A) in Ewing sarcoma: Role in tumor growth and immune evasion
Journal of the National Cancer Institute Feb 04, 2019
Heitzeneder S, et al. - Researchers focused on the biological roles for pregnancy-associated plasma protein A (PAPP-A) in Ewing sarcoma (EWS) in vitro and in vivo in NSG xenograft models as well as carried out RNA-sequencing on PAPPA knockout clones (n = 5) and controls (n = 3). They investigated highly differentially expressed molecules via a comprehensive characterization of the surfaceome of EWS by comparing RNA expression of cell surface proteins in EWS (n = 120) vs normal tissues (n = 42). Eleven highly differentially overexpressed genes were identified in EWS surfaceome analysis, with PAPPA ranking second in differential expression. Via regulating local insulinlike growth factor (IGF)-1 bioavailability, an essential survival role was demonstrated in EWS cell lines by genetic knockout of PAPPA and treatment with anti-PAPP-A antibodies. EWS growth in orthotopic xenografts was diminished by MAb-mediated PAPPA inhibition, which also improved the efficacy of anti-IGF-1R treatment. Induction of interferon (IFN)-response genes, including proteins associated with antigen processing/presentation, was seen as a result of PAPPA knockout in EWS cell lines. In PAPPA-low EWS tumors, gene expression profiles were enriched for immune response pathways.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries